Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity

Affiliations

Sung Hee Choi: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Jay Thomas Myers: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Suzanne Louise Tomchuck: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Melissa Bonner: Department of Pathology Case Western Reserve University School of Medicine Cleveland Ohio USA
Saada Eid: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Daniel Tyler Kingsley: Department of Pathology Case Western Reserve University School of Medicine Cleveland Ohio USA
Kristen Ashley VanHeyst: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Seong‐Jin Kim: MedPacto Inc. Seoul Republic of Korea
Byung‐Gyu Kim: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA
Alex Yee‐Chen Huang: Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA

Abstract

No abstracts available.

ISSN: 2523-3548 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/25233548